
- Mount Sinai Doctors
- Treats Adults
- Accepting New Patients
Suchitra Sundaram, MD
Hematology-Oncology, Cancer (Oncology)
About Me
Dr. Suchitra Sundaram is an Assistant Professor of Medicine (Hematology and Medical Oncology) at the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. Dr. Sundaram provides clinical care fully dedicated to patients with lymphoma (non-hodgkin and hodgkin lymphoma) and chronic lymphocytic leukemia (CLL). Her research focuses on the development of novel targeted therapies in lymphoma and CLL and studying practice patterns and clinical outcomes of lymphoma in the real world setting. Dr. Sundaram is a primary investigator and and a co-investigator on several multi-center clinical trials that tested combinations of novel agents and immunotherapies to precisely target lymphoma while decreasing the intensity of side effects. Dr. Sundaram was also involved in translational and laboratory based research projects and contributed to studying the biology of treatment resistance in lymphoma/CLL, evaluating novel small-molecule inhibitors targeting key-regulatory pathways in lymphomas and identification of biomarkers of response. She has authored and co-authored several articles in scientific journals, as well as had several national level meeting abstracts and presentations. Dr. Sundaram has served on the NCCN CLL- Hairy Cell Leukemia practice guidelines committee and has been involved in speaker events with the Leukemia Lymphoma Society and the Lymphoma Research Foundation. Dr. Sundaram is a Lymphoma Research Foundation Scholar and is committed to continuing her research in lymphoma outcomes studies and clinical trials with the hope to provide the most appropriate individualized care plan for her patients.
Language
English
Position
ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
- Adult Non-Hodgkin's Lymphoma
- Bone Marrow Biopsy
- Cancer Treatment
- Enlarged Lymph Nodes
- Hairy Cell Leukemia
- Hematologic Malignancies
- Hematology
- Hodgkin's Disease
- Hodgkin's Lymphoma
- Lymphoma
- Mantle Cell Lymphoma
- Primary Central Nervous System Lymphoma
Education
MD, Lokmanya Tilak Municipal Medical College
Residency, Internal Medicine
Cleveland Clinic Foundation
Fellowship, Hematology & Oncology
University Hospitals Cleveland Medical Center
Certifications
American Board of Internal Medicine
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information. Patients with Anthem Blue Cross Blue Shield (formerly known as Empire) or Molina insurance: please visit the linked pages in this message before booking to find out if out-of-network costs may apply to your next visit.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Affinity Medicaid-Medicare-Essential Exchange
- Amidacare Medicaid
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - HealthPlus Medicaid
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- Partners Health Plan
- Senior Whole Health
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VNSNY Select Health Medicaid
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab. Taylor R. Brooks, Emily C. Zabor, Yohanna B. Bedelu, Xi Yang, Yasmin H. Karimi, Adrienne N. Nedved, Yucai Wang, Nikita Dave, Daniel J. Landsburg, Kelsey Baron, Boyu Hu, Daniel C. Trotier, Priyanka A. Pophali, Jordan Miller, Natalie Grover, Catherine Reinert, Ajay Major, Tenley Schwarz, Krish Patel, Kiarash Salafian, Emily Ayers, Suchitra Sundaram, Joshua D. Brody, Marshall McKenna, Yun Kyoung Ryu Tiger, Megan Sears-Smith, Nilanjan Ghosh, Chelsea Peterson, Cyrus Khan, Sean P. Bliven, Mayur Narkhede, Alyssa Gibson, Justin Kline, Javier Munoz, Rodolfo Garza-Morales, Carrie I. Ho, Stephen D. Smith, Alex Niu, Francisco Hernandez-Ilizaliturri, Fadzai Chinyengetere, Sandeep Dave, Nayef Abdel-Razeq, Muhamad Alhaj Moustafa, Paolo F. Caimi, Brian T. Hill. Blood
- An aggressive hematolymphoid neoplasm with homozygous SMARCB1 loss shows response to EZH2 inhibition. Iman Sarami, Amy S. Duffield, Suchitra Sundaram, Douglas I. Lin, Christian Salib, Shafinaz Hussein, Siraj El Jamal, Nasrin Ghesani, Busra Cangut, Bruce E. Petersen. Haematologica
- High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series. Narendranath Epperla, Adam S. Zayac, Daniel J. Landsburg, Allison M. Bock, Grzegorz S. Nowakowski, Emily C. Ayers, Mark Girton, Marie Hu, Amy Beckman, Shaoying Li, L. Jeffrey Medeiros, Julie E. Chang, Habibe Kurt, Jose Sandoval-Sus, Mohammad Ali Ansari-Lari, Shalin K. Kothari, Anna Kress, Mina L. Xu, Pallawi Torka, Suchitra Sundaram, Stephen D. Smith, Kikkeri N. Naresh, Yasmin Karimi, David A. Bond, Andrew M. Evens, Seema G. Naik, Manali Kamdar, Bradley M. Haverkos, Reem Karmali, Umar Farooq, Julie M. Vose, Paul Rubinstein, Amina Chaudhry, Adam J. Olszewski. Blood advances
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Sundaram during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Cardinal Health
- Curio Science
Editorial Services
- Medscape
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.